Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Diagnosis and Treatment of Localized Scaly Lesions

Introduction to Diagnostic Considerations

  • The British Journal of Dermatology recommends that actinic keratoses present as discrete patches of erythema and scaling on sun-exposed skin in middle-aged and elderly individuals, and hypertrophic AKs are thicker, more keratotic lesions that may be amenable to curettage 1, 2.
  • The National Comprehensive Cancer Network suggests that curettage and electrodesiccation achieves 5-year cure rates of 91-97% for properly selected low-risk basal cell carcinomas 7.

Diagnostic Approach

  • The British Journal of Dermatology notes that middle-aged or elderly individuals with chronically sun-exposed skin are more likely to have actinic keratosis 1, 2.
  • The British Journal of Dermatology recommends that if a lesion fails to respond to standard actinic keratosis therapy, further evaluation with histology is essential to rule out invasive squamous cell carcinoma 4.

Treatment Implications

  • The British Journal of Dermatology states that for hypertrophic AKs, curettage is rated as the best treatment option compared to other modalities 1, 2.
  • The Journal of the National Comprehensive Cancer Network notes that curettage with cautery or electrodesiccation is effective for properly selected Bowen's disease or basal cell carcinoma lesions 5, 7.
  • The British Journal of Dermatology recommends that curettage addresses focal lesions but does not treat the field of actinic damage 3, 4.

Critical Pitfalls to Avoid

  • The Journal of the National Comprehensive Cancer Network advises against using curettage in areas with terminal hair growth due to the risk of incomplete removal of follicular extension 7.
  • The British Journal of Dermatology warns that failure to obtain histology on treatment-resistant lesions may miss invasive squamous cell carcinoma 3, 4.